1. Optovue Reaches Milestone with Placement of 1000th RTVue FD-OCT

    FREMONT, Calif., Nov 13, 2008 (BUSINESS WIRE) -- Optovue, a pioneer in optical coherence tomography (OCT), announced that the company has now shipped more than 1000 RTVue(TM) systems worldwide. In just two years since its introduction, RTVue has gained rapid acceptance by leading clinicians around the globe. RTVue is the first and only FDA-cleared spectral domain OCT capable of imaging both the front (cornea) and back (retina) of the eye in a single system. In addition, RTVue offers unprecedented analytical capabilities, allowing physicians to evaluate tissue at greater depths and with more detail than is possible with other commercially available ...
    Read Full Article

    Login to comment.

  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Quotes

    1. When our practice considered the options for spectral domain OCT, we concluded that RTVue offered the best combination of performance and value.
    2. Our strong sales performance, even in the face of much larger competitors, speaks to the quality of our technology and our ability to meet the needs of clinicians.
  3. Topics Mentioned